After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Lexeo Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Lexeo Therapeutics Inc is $694.11M. A total of 0.71 million shares were traded on the day, compared to an average of 1.26M shares.
In the most recent transaction, Townsend Richard Nolan sold 1,127 shares of LXEO for 9.27 per share on Nov 18 ’25. After the transaction, the Chief Executive Officer now owns 240,991 company shares. In a previous transaction on Nov 18 ’25, Adler Eric sold 615 shares at 9.27 per share. LXEO shares that Chief Medical Officer owns now total 72,646.
Among the insiders who sold shares, See Tai Sandi disposed of 386 shares on Nov 18 ’25 at a per-share price of $9.27. This resulted in the Chief Development Officer holding 65,476 shares of LXEO after the transaction. In another insider transaction, Robertson Jenny sold 549 shares at $9.27 per share on Nov 18 ’25. Company shares held by the Chief Legal Officer now total 68,381.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, LXEO has a high of $10.38 and a low of $1.45.
As of this writing, LXEO has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.21 per share and a lower estimate of -$0.35. The company reported an EPS of -$0.78 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. LXEO’s latest balance sheet shows that the firm has $135.86M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $7.45M in liabilities at the time. Its Book Value Per Share was $2.20, while its Total Shareholder’s Equity was -$55.60M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LXEO is Buy with a score of 4.73.
